191 related articles for article (PubMed ID: 12167586)
1. Mechanisms of secondary hyperparathyroidism.
Silver J; Kilav R; Naveh-Many T
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
[TBL] [Abstract][Full Text] [Related]
2. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
Silver J; Levi R
Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of parathyroid dysfunction in end-stage kidney disease.
Levi R; Silver J
Pediatr Nephrol; 2005 Mar; 20(3):342-5. PubMed ID: 15549412
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms of secondary hyperparathyroidism.
Silver J; Levi R
Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
[TBL] [Abstract][Full Text] [Related]
7. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
Cañadillas S; Canalejo A; Santamaría R; Rodríguez ME; Estepa JC; Martín-Malo A; Bravo J; Ramos B; Aguilera-Tejero E; Rodríguez M; Almadén Y
J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
Naveh-Many T; Rahamimov R; Livni N; Silver J
J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
[TBL] [Abstract][Full Text] [Related]
10. Phosphate and the parathyroid.
Silver J; Naveh-Many T
Kidney Int; 2009 May; 75(9):898-905. PubMed ID: 19129794
[TBL] [Abstract][Full Text] [Related]
11. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
[TBL] [Abstract][Full Text] [Related]
12. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure.
Tominaga Y; Sato K; Tanaka Y; Numano M; Uchida K; Takagi H
Clin Nephrol; 1995 Nov; 44 Suppl 1():S42-7. PubMed ID: 8608662
[TBL] [Abstract][Full Text] [Related]
13. The genetic background of uremic secondary hyperparathyroidism.
Aucella F; Morrone L; Stallone C; Gesualdo L
J Nephrol; 2005; 18(5):537-47. PubMed ID: 16299679
[TBL] [Abstract][Full Text] [Related]
14. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells.
Nielsen PK; Feldt-Rasmussen U; Olgaard K
Nephrol Dial Transplant; 1996 Sep; 11(9):1762-8. PubMed ID: 8918619
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of secondary hyperparathyroidism.
Silver J
Nephrol Dial Transplant; 2000; 15 Suppl 5():2-7. PubMed ID: 11073267
[No Abstract] [Full Text] [Related]
16. Pathogenesis of parathyroid hyperplasia in renal failure.
Cozzolino M; Brancaccio D; Gallieni M; Galassi A; Slatopolsky E; Dusso A
J Nephrol; 2005; 18(1):5-8. PubMed ID: 15772917
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
Fernández Martín JL; González Suárez I; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
[TBL] [Abstract][Full Text] [Related]
19. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Nechama M; Ben-Dov IZ; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F795-800. PubMed ID: 19129257
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
Rahamimov R; Silver J
Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
